Naltrexone in the management of fibromyalgia: latest findings
Chronic inflammatory diseases are complex to treat and have an impact on a large number of patients. Due to the difficulty of treating these diseases and the great impact on quality of life, patients often seek off-label medicines to gain relief from symptoms.
Naltrexone, a drug used to treat alcohol dependence and opioid addiction, has been used in low doses off-label for treatment of pain and inflammation in fibromyalgia, multiple sclerosis, Crohn’s disease and other diseases.
A research group has now looked at the evidence to see if low-dose naltrexone is safe, tolerated and helpful in people with chronic pain and inflammatory conditions.
They found that low-dose naltrexone has a good safety profile and is tolerated but fewer studies showed that it actually worked. Most focused on subjective measures such as quality of life or self-reported pain. The team concludes:
“These studies do demonstrate that low-dose naltrexone has subjective benefits over placebo, but evidence for more objective measures is limited.”
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.